Tasly Holding Group Co., Ltd. Files IPO Prospectus to Accelerate Global Health Innovation

CooperationProject：

1. Leveraging the comprehensive support from Tasly Group in internationalization, R&D, manufacturing, marketing, and capital, we continuously explore and promote new

Incubation of Innovative and Entrepreneurial Projects.

n Support for International Expansion: By pursuing global research, regulatory filings, and market launch of Compound Danshen Dripping Pills, a comprehensive pathway for the internationalization of modern traditional Chinese medicine has been established, thereby

Possesses in-depth knowledge of international drug registration processes and the global pharmaceutical industry.

n High-End Production Technology Support: Fully Digitalized and Automated Extraction Control System, World-Leading Proprietary Micro-Drip Pill Preparation Process, Creating

High-frequency cryogenic dripping technology and equipment, along with innovations in quality standards across the entire industrial chain, have gradually established an integrated technical system with independent intellectual property rights unique to China.

and the pharmaceutical equipment system.

n Multi-domain R&D Support: Focusing on unmet clinical needs, particularly in major disease areas, large markets, key product categories, and serialized product lines

The domain boasts extensive R&D experience, features an innovative scientific research system, and adheres to lean manufacturing and intelligent manufacturing to develop and enrich modern traditional Chinese medicine products.

biopharmaceutical and chemical drug product portfolios; meanwhile, leveraging technological advantages in the biopharmaceutical sector, it has built a health care framework centered on consumers’ emerging health needs

Possesses a product R&D system for functional foods and has digitalized, standardized, and large-scale production capabilities.

n Broad-Coverage Innovative Marketing Network Support: The pharmaceutical marketing group currently possesses more than150,000 marketing terminals deployed, focusing on integrated marketing and precision

Precision marketing and specialized pharmaceutical e-commerce projects, while collaborating with the big health marketing team to integrate modern retail channels, franchise channels, and direct sales

channels, as well as e-commerce channels, for coordinated development.

n E-commerce Service Support: Tianshili Diabetes“Special Outpatient Drug Delivery” services, leveraging the “Online Hospital Platform” and third-party pharmaceutical e-commerce platforms

Service institutions and community health management service centers continuously innovate the connotation of their services, forming an O2O full-process closed-loop service model based on chronic disease management.

System.

n Support for Smart Healthcare Service Systems:“A three-tier system centered on ‘high-end therapeutic research hospitals, specialized rehabilitation hospitals, and community health management centers’”

Sub-business System: Focusing on major diseases as the entry point, establish a precision diagnosis and treatment platform for major diseases, integrate internet technology, and build a comprehensive patient guidance and triage system.

system, enabling effective connectivity and interaction in business operations.

n Support for Centralized Procurement and Traceability of Traditional Chinese Medicinal Materials: Centered on the development and operation of authentic medicinal material resources, it has formed the offline physical market of Anguo Digital Chinese Medicine Capital and

Digital Materia Medica“An online B2B multi-sided platform business model for medicinal herb trading reshapes the industrial value chain, creating a new paradigm of sharing and mutual benefit in traditional Chinese medicine”

material ecosystem.

n Support for the Innovative Children's Education Industry: Centered on Huaxia Future’s children’s education industry, it boasts robust educational resources, brand assets, and customer base

leveraging advantageous resources such as sources, to extend services and integrate and share resources, expand the two-wing industries of health services and cultural media, and build children's education

an ecosystem for education, cultural dissemination, and health management.

2. The private advisory board mechanism brings together multiple sectors, including pharmaceutical manufacturing, pharmaceutical distribution, chain pharmacies, health examination institutions, health kiosks, and insurance organizations.

Leading industry enterprises, converging multiple innovative resource elements such as capital, technology, information, and customers, to form extensive cross-sector linkages and mutual

Movement.

n Industrial Alliance Resource Support: Strategic Deployment of the Full Ecosystem in Pharmaceuticals and Health.

n Support from offline chain pharmacy resources: for thousands of chain pharmacies, including Tasly Grand Pharmacy Chain, Gansu Zhongyou Pharmaceutical, and Chongqing Heping Pharmacy Chain

Fang has influence.

n Support from Resources in Related Fields: Established strong partnerships with multiple insurance providers, medical examination institutions, and health kiosk enterprises, including Taikang Life Insurance and Haoyitong.

Partnership.

CombinedWorkflow:

Comprehensively absorb a rich pipeline of innovative projects, aggregate talent and resources, fully open up industrial resources, and provide services for project matching, screening, evaluation, and investment mechanisms.

1. Information Aggregation: Accept project sources through all-around, multi-channel approaches, link with resources such as external media and university alliances, and gather outstanding startup projects and entrepreneurial partners through startup competitions and high-level forums.

2. Precise Matching and Screening of Projects: Assist startups in exploring new project development spaces through forward-looking industry insights from top-level design, and seek precisely matched project investment opportunities

3. Technology and Investment Assessment: In the project screening process, we fully leverage Tasly’s multi-tiered pool of qualified experts across various specialized fields, while synergizing with both proprietary and collaborative funds to enhance the investment opportunities for innovative projects.

4. Precision Incubation: Leveraging multi-party industrial resources for targeted incubation to improve the success rate of innovative project incubation

5. Fund Linkage：Leverage Tasly’s proprietary fund cluster to strengthen resource integration within the industrial ecosystem, while utilizing diverse capital market tools to drive the development of innovative projects with capital as the engine.